T h e tissue plasminogen activator (tPA)/plasmin proteolytic system has been implicated in both physiological and pathological processes in the mammalian brain. The physiological roles include facilitating neurite outgrowth and pathfinding. T h e pathological role involves mediating a critical step in the progression of excitotoxin-induced neurodegeneration. Mechanistically, tPA appears to function through two pathways. T h e first pathway proceeds via its well established ability to convert plasminogen into plasmin. Plasmin then either promotes neuronal death via both the degradation of the extracellular matrix and the establishment of chemoattractant gradients for microglia, or facilitates neurite outgrowth through the processing of extracellular matrix proteoglycans. T h e second pathway for tPA does not involve its proteolytic activity: rather tPA functions as an agonist to stimulate a cell-surface receptor on microglia (the macrophage-like immunocompetent cells of the central nervous system) and results in their activation. Once activated after neuronal injury, microglia contribute to the ensuing neurodegeneration. Using tPA as a link between neurons and microglia, we are focusing on understanding their communication and interactions in the normal and diseased central nervous system.
Introduction
Tissue plasminogen activator (tPA), a member of the fibrinolytic system, is a serine protease that converts the zymogen plasminogen into the active protease plasmin [l], thus initiating a potent proteolytic cascade. Mutant mice that lack functional tPA are viable and overtly phenotypically normal [2]. However, accumulating evidence in wild-type and tPA-deficient mice indicates that tPA plays an important role in the central nervous system (CNS) in neuronal plasticity and reorganKey words: neurodegenerative disease. plasticity, microglia.
Abbreviations used: CNS, central nervous system, DG, dentate gyms; MS, multiple sclerosis; tPA, tissue plasminogen activator. suggesting that it is the tPA/plasmin proteolytic cascade that mediates neuronal death in the mouse hippocampus.
One possible caveat for the observed phenotype (resistance to excitotoxins) could be that the mice had some developmental abnormality, since they developed in the absence of the plasminogen activator cascade. However, when purified tPA protein was infused into the hippocampi of adult tPA-'-mice prior to the delivery of the excitotoxin, the tPA-'-pyramidal neurons became just as susceptible to excitotoxic death as the wild-type pyramidal neurons, indicating that tPA and plasmin were acting acutely to promote neuronal death [ I l l .
Plasminogen and tPA are synthesized locally in the mouse brain, presumably to be in place for use shortly after neuronal injury [lo] (in addition to any potential physiological functions in the normal brain). It is these CNS-expressed tPA and plasminogen that promote neurodegeneration, rather than the influx of plasminogen via disrupted blood-brain barrier, as was shown by assessing the timing of observed neuronal injury and opening of the blood-brain barrier [12].
A working hypothesis for the mechanism through which the tPA/plasmin proteolytic system promotes neurodegeneration is via the degradation of proteins in the extracellular matrix. This hypothesis states that plasmin destroys the layer upon which neurons are laid and form their network (anoikis) [13]. In support of this hypothesis, plasmin was shown to degrade laminin soon after excitotoxic injury [14]. Recently, another hypothesis, which suggests that tPA potentiates signalling mediated by glutamatergic receptors by proteolytically regulating N-methyl-D-aspartate receptors and thus increasing influx of calcium, has been put forward [15] .
tPA is expressed by neurons and microglia in the CNS. Microglia are the immunocompetent cells of the CNS and they function in both neuroprotection and neurotoxicity. They reside in the brain in a ramified (resting) form [16] . When microglia are stimulated, they undergo a process called activation [17] . Activation consists of various changes to these cells, including migration to the site of injury, local proliferation, changes in gene expression (upregulation of cell surface proteins, presentation of cell surface antigens, secretion of cytokines and proteases) and phagocytosis [17] . During activation, reactive oxygen and nitrogen species are also produced by microglia [18] . We and others have shown that microglia are neurotoxic when activated and that inhibiting or delaying microglial activation can result in neuroprotection [ 19,201. Activated microglia are associated with several neuropathological conditions, such as Alzheimer's disease [21-231, stroke [24] , and multiple sclerosis (MS) [25, 26] .
Although the activation of plasminogen by tPA is required for neurodegeneration [l 11, we have also found that tPA mediates microglial activation, and that it does so through some mechanism other than the conversion of plasminogen into plasmin [27] . Accordingly, tPA-'-microglia display attenuated activation in response to excitotoxic stimuli in vivo. Moreover, tPA-'-microglia also display attenuated activation in culture in response to lipopolysaccharide [27] , providing a model system for in vitro studies. Using this system, we have found that tPA mediates microglial activation via its finger domain through binding to annexin I1 on the microglial cell surface [27a].
Zinc and tPA
It was reported recently that tPA can protect rat neuronal cells from zinc-induced toxicity by a mechanism that does not involve tPA's proteolytic activity [28] . Zinc is avery abundant trace element. T h e CNS contains high concentrations of zinc in the hippocampus, cortex and amygdala, in a free form and as a tightly bound component of proteins. In neurons, zinc is located in the presynaptic terminals in a chelatable form and its concentration may exceed 1 mM. It is thought that it is secreted from the terminals, in a manner similar to the excitatory neurotransmitter glutamate, and binds to post-synaptic glutamate receptors to modulate their function [29] . Intrahippocampal injections of zinc chloride in rats results in lesions; however, these are prevented when the zinc chelator N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (' T P E N ') is injected simultaneously [29] , demonstrating that it is the presence of free zinc that promotes toxicity [30] .
It is possible that zinc elicits a response analogous to excitotoxicity, because a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-and kainate-receptor activation potentiates zinc toxicity in cortical neurons. However, this does not appear to be the whole story, since toxicity induced via N-methyl-D-aspartate receptor activation is attenuated with the addition of zinc [31] .
So how does tPA protect from zinc toxicity ?
How does tPA, which, as we have shown, promotes excitotoxin-induced neurodegeneration, also act in a neuroprotective manner ? There have been several reports of potential interactions between zinc and tPA or between other serine proteases that are similar to tPA. One such report uses zincchelate agarose chromatography to purify tPA. This purification procedure causes tPA, which exists as a dimer in vivo, to dissociate into monomers [32] . Furthermore, the activity of other serine proteases can be modulated by zinc. Kallikrein 2 is inhibited by zinc, whereas the two subunits of mouse 7 s nerve growth factor, which belong to the kallikrein family of serine proteases, are stabilized by zinc. In addition, crystallographic evidence has suggested that zinc can bind to trypsin-like proteases (such as tPA) at subphysiological concentrations and act as a scaffold for binding of serine protease inhibitors. It can, therefore, mediate very potent inhibition of serine protease activity [33] . Taken together, these studies suggest that there could be a direct interactionlbinding between zinc and tPA. In such a scenario, the two effectors of cell death could titrate each other out and thus regulate neuronal survival.
tPA and neurodegenerative disease
Excitotoxicity has been hypothesized as the common mechanism through which several acute or chronic neurodegenerative diseases proceed [34] ; one such acute disease is cerebral ischaemia. When tPA-'-mice were subjected to transient focal ischaemia and subsequent reperfusion injury in the absence of fibrin clots, a significant decrease in the volume (almost by 50 yo) of the infarct size was observed [35-371. When tPA was delivered into the tPA-deficient mice during the reperfusion phase of the experimental paradigm, the infarct size increased to approximately wild-type levels [35] . Furthermore, a recent report demonstrated that delivery of an endogenous tPA inhibitor, neuroserpin, into the rat brain immediately after In Alzheimer's disease, it has been shown that tPA activity is increased in the presence of Pamyloid peptides of different lengths [42] . Furthermore, P-amyloid is also capable of stimulating microglial activation [43,44], and accumulation of activated microglia is evident around the deposits (plaques) of P-amyloid.
tPA/plasmin(ogen), phosphacan and neurite outgrowth
The expression of tPA protein in the mouse hippocampus localizes along the CA3 pyramidal layer and the dentate gyrus (DG) [45] . This expression pattern coincides with the region where mossy fibre (the axons of the D G granule cells) sprouting and reorganization occurs [46, 47] . This observation suggested to us that tPA might be involved in the reorganization and sprouting of the neural connections after excitation and stimulation [S]. We have explored this hypothesis in mice using a previously published protocol for stimulation of mossy fibre sprouting in the rat [48]. We found that the tPA/plasmin system is involved in the regulation of mossy fibre outgrowth after excitotoxin-stimulation of the amygdala [S]. This regulation involves two different events : neurite pathfinding through the supragranular layer, which is independent of tPA's proteolytic activity and plasmin, and the termination of neurite outgrowth, which is mediated by proteolytic cleavage of the chondroitin sulphate proteoglycan, phosphacan, by plasmin.
Recently, a different chondroitin sulphate proteoglycan, NG2, was shown to interact and bind with plasminogen using surface plasmon resonance in a BIAcore instrument [49]. This interaction between NG2 and plasminogen (and angiostatin) has been speculated to promote cell proliferation and migration, and thus, to regulate angiogenesis. By analogy with plasminogen-NG2 binding, one can speculate that plasminogen may interact with phosphacan via a different domain than the serine protease domain, and thus localize appropriately the subsequent proteolytic cleavage of phosphacan. In that respect, it is very tempting to suggest that perineuronal microglia may contribute to this form of neuronal plasticity via their local activation by tPA and annexin 11, and subsequent secretion of additional proteases.
Conclusion
It is evident that tPA plays a critical role in the mammalian CNS. Physiological and tightly regulated control of tPA by its localization and its inhibitors is vital to normal C N S function and survival. However, when the control is lost owing to some pathological event, signalling cascades both within neurons and among neurons, microglia and the other macroglia are initiated, which ultimately result in neuronal death. In that respect, understanding the interactions between these CNS cells, as well the steps that control tPA activity and release, will be critical in deciphering its role in neuronal survival and plasticity.
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